US › Healthcare

BillionToOne, Inc. Class A Common Stock (BLLN)

US · Healthcare · Diagnostics & Research

$142.25+3.59%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

$108.4M

Revenue YoY

+83.8%

Net profit

$18.0M

Profit YoY

+550.6%

EPS

$0.34

EPS estimate

$-0.01

Net margin

16.6%

EPS came in at 0.34 against a street estimate of -0.01 — a beat of 3489.0%.

Key statistics

Market cap

$6.37B

P/E

256.7

Forward P/E

0.0

P/B

12.60

Book value

$11.00

EPS (TTM)

$0.54

52-week high

$140.21

52-week low

$61.96

50-day MA

$112.26

200-day MA

$94.63

Analyst view

with an average price target of $123.86.

Shareholding

Insiders

38.14%

Institutions

37.60%

Largest institutional holders

Fund	Stake
Adams Street Partners LLC	3.72%
Baillie Gifford & Co Limited.	2.74%
Civilization Ventures Management, LLC	2.39%
BAMCO Inc	1.61%
T. Rowe Price Associates, Inc.	1.60%
Neuberger Berman Group LLC	1.54%
Wasatch Advisors LP	1.13%
NVP Associates LLC	1.12%

Recent filings & reports

Document	Date
Material agreement · Q2 2026	2026-06-29
Material agreement · Q2 2026	2026-06-16
Quarterly report · Q1 2026	2026-05-06
Results announced · Q2 2026	2026-05-06
Proxy statement · Q2 2026	2026-04-21
Annual report FY2025	2026-03-11
Results announced · Q1 2026	2026-03-04
Quarterly report · Q3 2025	2025-12-10

Readable in the app.

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for BillionToOne, Inc. Class A Common Stock — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.